Latest Breaking News On - Biosimilar related - Page 1 : comparemela.com

As we ring in the new year, we look back at the top legal developments of 2022 that could influence the market for biologics and biosimilars.

United statesRegeneron praluentAmgen repathaSupreme court grants cert to address enablementRegeneron pharmaceuticals incUs courtUs district courtUs supreme courtAmgen incAbbvie incFederal circuitCourt grants certAddress enablementRegeneron pharmaceuticalsBiosimilar relatedSeventh circuit affirms dismissal